AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
Dec 9, 2013
30016_dirs_2013-12-09_34813629-96f1-480f-b894-cdeb591318c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-12-05
Reporting Person: MAZELSKY JAY (Executive Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-12-05 | Non-Qualified Stock Option (right to buy) | $104.00 | A | 24501 | Acquired | 2023-12-04 | Common Stock (24501) | Direct |
| 2013-12-05 | Restricted Stock Unit | $ | A | 2404 | Acquired | Common Stock (2404) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (12/05/2014) of the date of grant.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (12/05/2014) of the date of grant.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13